Clinical Trial

Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry

Recruiting
View on ClinicalTrials.gov →
Summary
Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant. Because of the low incidence of this disease and the peculiar histological subtype, French authorities, in accordance with the recommendations of an expert group, recommended the implementation of a BIA-ALCL case registry, in connection with a national Multidisciplinary meeting (Réunion de Concertation Pluridisciplinaire nationale de recours- RCP). This registry is opened in France and in Belgium
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2020-01-06; most recent amendment 2026-01-12.
Trial Details
NCT Number NCT04220970
Lead Sponsor The Lymphoma Academic Research Organisation
Conditions Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)
Enrollment 150 participants
Start Date 2017-06-07
Primary Completion 2032-06-07 (estimated)
Study Completion 2032-06-07 (estimated)
Updated on ClinicalTrials.gov 2026-01-14